Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1989 3
1990 2
1991 15
1992 20
1993 28
1994 35
1995 119
1996 89
1997 114
1998 121
1999 116
2000 118
2001 149
2002 179
2003 128
2004 133
2005 161
2006 116
2007 118
2008 116
2009 121
2010 125
2011 127
2012 110
2013 125
2014 108
2015 100
2016 108
2017 93
2018 95
2019 113
2020 100
2021 89
2022 106
2023 99
2024 38

Text availability

Article attribute

Article type

Publication date

Search Results

3,282 results

Results by year

Filters applied: . Clear all
Page 1
CYP1A2 Polymorphism and Drug Co-administration Affect the Blood Levels and Adverse Effects of Pirfenidone.
Yang X, Wei J, Yang Y, He Y, Guo L, He X, Zhang L, Chen L. Yang X, et al. Ther Drug Monit. 2024 May 1. doi: 10.1097/FTD.0000000000001208. Online ahead of print. Ther Drug Monit. 2024. PMID: 38723157
Adverse drug reaction (ADR) incidence in the homozygous AA mutant group (28.0%) was significantly lower than that in the C carriers (CC+AC) (63.2%; P = 0.020), and ADR incidence in the A carriers (AC+AA) was considerably lower than that in the CC group (85.7%; P = 0.039). The C/D …
Adverse drug reaction (ADR) incidence in the homozygous AA mutant group (28.0%) was significantly lower than that in the C carriers (CC+AC) …
Attuning doped ZnO-based composites for an effective light-driven mineralization of pharmaceuticals via PMS activation.
Bujaldón R, Benamara M, Dhahri R, Gómez E, Serrà A. Bujaldón R, et al. Chemosphere. 2024 Jun;357:142127. doi: 10.1016/j.chemosphere.2024.142127. Epub 2024 Apr 23. Chemosphere. 2024. PMID: 38663678 Free article.
Their suitability was tested on a complex 60-ppm multi-pollutant solution (tetracycline, levofloxacin and lansoprazole). The activation strategy combined photocatalysis with peroxymonosulfate (PMS) as an environmentally friendly source of highly oxidative sulfate radicals. …
Their suitability was tested on a complex 60-ppm multi-pollutant solution (tetracycline, levofloxacin and lansoprazole). The activati …
Vonoprazan 10 mg or 20 mg vs. lansoprazole 15 mg as maintenance therapy in Asian patients with healed erosive esophagitis: A randomized controlled trial.
Xiao Y, Qian J, Zhang S, Dai N, Chun HJ, Chiu C, Chong CF, Funao N, Sakurai Y, Eisner JD, Xie L, Chen M. Xiao Y, et al. Chin Med J (Engl). 2024 Apr 20;137(8):962-971. doi: 10.1097/CM9.0000000000003068. Epub 2024 Mar 29. Chin Med J (Engl). 2024. PMID: 38654422 Free PMC article. Clinical Trial.
At 12 weeks, endoscopically confirmed EE recurrence was observed in 5/18, 2/20, and 7/20 of patients receiving vonoprazan 10 mg, vonoprazan 20 mg, and lansoprazole, respectively. TEAEs were experienced by 66.8% (157/235), 69.0% (156/226), and 65.3% (158/242) of patients re …
At 12 weeks, endoscopically confirmed EE recurrence was observed in 5/18, 2/20, and 7/20 of patients receiving vonoprazan 10 mg, vonoprazan …
Selection of lansoprazole from an FDA-approved drug library to inhibit the Alzheimer's disease seed-dependent formation of tau aggregates.
Imtiaz A, Shimonaka S, Uddin MN, Elahi M, Ishiguro K, Hasegawa M, Hattori N, Motoi Y. Imtiaz A, et al. Front Aging Neurosci. 2024 Mar 26;16:1368291. doi: 10.3389/fnagi.2024.1368291. eCollection 2024. Front Aging Neurosci. 2024. PMID: 38633982 Free PMC article.
After AD seed-induced real-time quaking-induced conversion, lansoprazole was selected as the most suitable drug for repositioning. ...Alanine replacement of the predicted binding site to an AD filament indicated the involvement of Q351, H362, and K369 in lansoprazole …
After AD seed-induced real-time quaking-induced conversion, lansoprazole was selected as the most suitable drug for repositioning. .. …
Proton Pump Inhibitors and Cancer Risk: A Comprehensive Review of Epidemiological and Mechanistic Evidence.
Sawaid IO, Samson AO. Sawaid IO, et al. J Clin Med. 2024 Mar 28;13(7):1970. doi: 10.3390/jcm13071970. J Clin Med. 2024. PMID: 38610738 Free PMC article. Review.
Potentially, the PubMed citations count suggests that the PPIs omeprazole and lansoprazole are more associated with cancer than pantoprazole and esomeprazole. ...
Potentially, the PubMed citations count suggests that the PPIs omeprazole and lansoprazole are more associated with cancer than panto …
Greenness-sustainability metrics for assessment smart-chemometric spectrophotometric strategy for evaluation of the combination of six gastric proton-pump inhibitors with two selected impurities.
Amin KFM. Amin KFM. MethodsX. 2024 Mar 28;12:102670. doi: 10.1016/j.mex.2024.102670. eCollection 2024 Jun. MethodsX. 2024. PMID: 38577411 Free PMC article.
These chemometric models were implemented for assessing six proton-pump inhibitors Omeprazole, Esomeprazole, Lansoprazole, Pantoprazole, Rabeprazole, and Dexlansoprazole along with two selected official impurities, namely 4-Desmethoxy omeprazole impurity and Rabeprazole-im …
These chemometric models were implemented for assessing six proton-pump inhibitors Omeprazole, Esomeprazole, Lansoprazole, Pantoprazo …
Analysis and monitoring of drug therapy in a patient with peptic ulcer complicated by infection: A case report.
Gou YP, Huang Y, Chen L, Zheng W, Zheng YH. Gou YP, et al. World J Clin Cases. 2024 Mar 16;12(8):1530-1535. doi: 10.12998/wjcc.v12.i8.1530. World J Clin Cases. 2024. PMID: 38576803 Free PMC article.
Additionally, the pharmacist suggested changing famotidine to lansoprazole for acid suppression and gastroprotective treatment, combined with Chinese patent medicine such as Kangfuxin Liquid. ...
Additionally, the pharmacist suggested changing famotidine to lansoprazole for acid suppression and gastroprotective treatment, combi …
Repurposing lansoprazole to alleviate metabolic syndrome via PHOSPHO1 inhibition.
Wu Y, Xin J, Li X, Yang T, Liu Y, Zhao Y, Xie W, Jiang M. Wu Y, et al. Acta Pharm Sin B. 2024 Apr;14(4):1711-1725. doi: 10.1016/j.apsb.2024.01.001. Epub 2024 Jan 4. Acta Pharm Sin B. 2024. PMID: 38572109 Free PMC article.
In this study, our bioinformatic analysis first predicted an association between obesity and lansoprazole (LPZ), a commonly prescribed drug for gastrointestinal ulcers. ...
In this study, our bioinformatic analysis first predicted an association between obesity and lansoprazole (LPZ), a commonly prescribe …
A systematic review with meta-analysis: Efficacy and safety of potassium-competitive acid blocker compared with proton pump inhibitor in the maintenance of healed erosive esophagitis.
Simadibrata DM, Lesmana E, Pratama MIA, Sugiharta AJ, Winarizal AS, Lee YY, Syam AF. Simadibrata DM, et al. JGH Open. 2024 Mar 22;8(3):e13053. doi: 10.1002/jgh3.13053. eCollection 2024 Mar. JGH Open. 2024. PMID: 38523708 Free PMC article. Review.
Likewise, compared to lansoprazole 15 mg, any TEAEs were significantly greater with vonoprazan 20 mg (RR 1.10; 95% CI 1.01-1.20) but not vonoprazan 10 mg. CONCLUSION: Vonoprazan 10 and 20 mg were superior to lansoprazole 15 mg in the maintenance of the healing of EE …
Likewise, compared to lansoprazole 15 mg, any TEAEs were significantly greater with vonoprazan 20 mg (RR 1.10; 95% CI 1.01-1.20) but …
DNA adductomics aided rapid screening of genotoxic impurities using nucleosides and 3D bioprinted human liver organoids.
Li Y, Xu C, Zhou X, Li J, Xu S, Tu Y, Mu X, Huang J, Huang Q, Kang L, Wang H, Zhang M, Yuan Y, Wu C, Zhang J. Li Y, et al. Talanta. 2024 Jun 1;273:125902. doi: 10.1016/j.talanta.2024.125902. Epub 2024 Mar 15. Talanta. 2024. PMID: 38508126
Subsequently, the genotoxicity is confirmed in human by 3D bioprinted human liver organoids. To verify the feasibility of the approach, lansoprazole chloride compound (Lanchlor), a PGI during the synthesis of lansoprazole, was selected as the model drug. ...
Subsequently, the genotoxicity is confirmed in human by 3D bioprinted human liver organoids. To verify the feasibility of the approach, l …
3,282 results

Searches related to "lansoprazole"